Vedere Bio Funding: $77M Raised, Series A (2021)

Vedere Bio funding overview

Vedere Bio is based in Cambridge, Massachusetts. Vedere Bio has raised $77M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Vedere Bio runs through 2021; nothing later has been disclosed. Investors on record include Octagon Capital, Samsara BioCapital, Casdin Capital, Atlas Venture, Mission BioCapital, The RD Fund. 6 distinct backers are named across the disclosed rounds.

Vedere Bio at a glance

Total raised: $77M
Latest round: Series A
Latest round date: January 2021
Headquarters: Cambridge, Massachusetts
Notable investors: Octagon Capital, Samsara BioCapital, Casdin Capital, Atlas Venture, Mission BioCapital, The RD Fund

Frequently asked about Vedere Bio funding

How much has Vedere Bio raised?: Vedere Bio has raised $77M in total disclosed funding across the rounds on record.
Who has invested in Vedere Bio?: Octagon Capital, Samsara BioCapital, Casdin Capital, Atlas Venture, Mission BioCapital, The RD Fund are named among the investors backing Vedere Bio.
What was the latest Vedere Bio funding round?: The most recent disclosed round is a Series A, announced in January 2021.
Where is Vedere Bio based?: Vedere Bio is based in Cambridge, Massachusetts.
When did Vedere Bio last raise?: The last disclosed Vedere Bio round closed in January 2021 at Series A.

We update the Vedere Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.

Vedere Bio Funding: $77M Raised, Series A (2021)

Vedere Bio funding overview

Vedere Bio at a glance

Frequently asked about Vedere Bio funding

Companies related to Vedere Bio (28)

Browse related funding lists (8)